Karen Jones

Prof Karen Jones is a distinguished leader in medical imaging, with a stellar academic and research background. Prof Jones was the first nuclear medicine technologist in Australia to complete a PhD and is a champion of her field. As President of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM) and former Chair of both the ANZSNM Technologist Special Interest Group (TSIG) and Executive Committee of the Australasian Radiopharmaceutical Trials Network (ARTnet), she has significantly influenced the profession. Her pioneering research on gastric emptying and postprandial hypotension, utilising advanced imaging techniques, has set new standards in the field. Prof Jones’ strategic vision and leadership continue to drive innovation and excellence in nuclear medicine, benefiting both the scientific community and clinical practice.

Lena Oestreich

Lena Oestreich is an NHMRC Emerging Leadership Fellow and Group Leader at the Centre for Advanced Imaging (CAI) within the Australian Institute for Bioengineering and Nanotechnology (AIBN), holding a joint appointment as a Senior Lecturer in the University of Queensland’s School of Psychology. Her primary research interests lie at the intersection of computational psychiatry and clinical neuroimaging. She is particularly focused on studying mental illnesses from a symptom-oriented perspective, utilizing big data and advanced multimodal data.

Lidia Matesic

Lidia Matesic completed a PhD in organic and medicinal chemistry at the University of Wollongong in 2011. She then commenced at ANSTO as a post-doctoral fellow and later on, as a radiochemist. During her research career she has focussed on the development of radiopharmaceuticals for cancer and neurological disorders. In 2012 she was awarded an Early Career Fellowship to work at Centre Cyceron (Caen, France) on the development of new PET imaging agents to diagnose stroke.

Lidia has expertise in radiolabelling optimisation, radiotracer production for preclinical studies, radiotracer characterisation, organic synthesis and student supervision. Currently, she is a Principal Radiochemist and the Radiopharmaceuticals Manager at ANSTO, leading a team of radiochemists researching the use of therapeutic radioisotopes to advance the development, manufacturing and translation of radiopharmaceuticals into preclinical and clinical studies.

Arif Gulzar

Dr. Arif Gulzar has obtained doctorate degree in Material Science and Engineering. His research focuses on cyclotron operation for the production of novel radioisotopes such as 68Ga etc and chelator free radiolabelling of nanoparticles for cancer theragnostic.

Miao Cao

Miao Cao obtained his Ph.D. from The University of Melbourne in the fields of clinical neuroscience and neuroimaging. During his PhD training based at St Vincent’s Hospital Melbourne, he developed a unique combination of neuroimaging and dynamical models to better localise brain regions that are target for epilepsy surgery. Since 2021, he has further received post-doctoral research training at School of Physics Peking University to develop novel dynamical models for electromagnetic source imaging, aiming to better understand pathological and physiological neural dynamics. From 2024, he joined Swinburne Neuroimaging (SNI) as the informatics fellow.

Hiu Lam

Dr. Hiu Chun Lam completed his Ph.D. at the University of Adelaide under the supervision of A/Prof. Jonathan George, followed by postdoctoral training at Peking University under Professor Xiaoguang Lei. In 2020, Hiu joined the Molecular Imaging and Therapy Research Unit (MITRU) at the South Australian Health and Medical Research Institute (SAHMRI) as a radiochemist. In MITRU, Hiu develops the manufacturing process of radioisotopes and radiopharmaceuticals for clinical trials and special access schemes. He is also leading several pre-clinical projects including drug discovery program for novel radiopharmaceuticals.

Anne-Marie Lansdown

Anne-Marie Lansdown is an experienced public service and higher education Senior Executive and was one of the original architects of the National Collaborative Research Infrastructure Strategy (NCRIS). She was Deputy Chief Executive of Universities Australia, leading policy for Australia’s peak university organisation.

She is a Council Member of the University of Canberra, a Director at Collaborative Research Australia, an Advisory Council Member at the ARC Centre for Synthetic Biology, a Board Director for Australian Research Data Commons (ARDC), and previously served as Board Director for the Giant Magellan Telescope Organisation.

Anne-Marie has previously held executive positions with the Office of Australia’s Chief Scientist, the Australian Government Department of Innovation, Industry, Science and Research, and the departments of Education and Communications. Her international experience includes the United Nations and the Organisation for Economic Cooperation and Development (OECD).

Arkiev D’Souza

Dr. Arkiev D’Souza is a specialist in pipeline development, automation, and implementation with a focus on neuroimaging. He earned his PhD by leveraging advanced MRI techniques to quantitatively assess skeletal muscle structure in individuals affected by muscle contracture, a condition commonly seen in stroke survivors and children living with cerebral palsy. Following his graduation, Arkiev continued to contribute to the field of neuroimaging as a research officer and post-doctoral research associate. In these roles, he successfully implemented advanced diffusion analysis pipelines in both healthy and patient cohorts. Currently, as a neuroimaging analysis fellow, Arkiev is dedicated to ensuring that cutting-edge neuroimaging analysis pipelines are readily available to MRI users within the NIF network.

Jun Cao

Jun Cao obtained his PhD at The University of New South Wales and Neuroscience Research Australia, supervised by Prof. Caroline (Lindy) Rae and A/Prof. Socrates Dokos, after completing Bachelor of Engineering (Electronics Engineering) and Master of Engineering (Signal Processing). His PhD work focused on brain conductivity imaging using magnetic resonance electrical properties tomography (MREPT) and its applications.

Roslyn Francis

A/Prof Francis is an academic Nuclear Medicine Physician. She is A/Prof of Molecular Imaging with University of Western Australia and is Head of Department of Nuclear Medicine/ WA PET Service at Sir Charles Gairdner Hospital.

A/Prof Francis obtained her medical degree at UWA before travelling to the UK to undertake a Cancer Research UK Clinical Research Fellowship and a PhD at the Royal Free Hospital London on antibody therapies. On returning to Australia she completed specialist training in Nuclear Medicine, and continued her research endeavors, resulting in a joint clinical/academic appointment since 2010.

A/Prof Francis has a particular interest in novel molecular imaging /PET tracers, and has contributed to research in oncology, cardiology, neurology and inflammatory diseases. She has expertise in clinical trials in Nuclear Medicine, including trial design and conduct. She has a particular interest in quantitative data and in comparable data-sets, which is built on the foundation of harmonization and quality in Nuclear Medicine clinical trials.

A/Prof Francis has local, national and international collaborations. She is co-investigator on a recent NHMRC CRE grant for National Centre for Asbestos Related Diseases, led by Prof Nowak. A/Prof Francis leads the molecular imaging component of this integrated research program. A/Prof Francis is a co-investigator on several multicentre collaborative clinical trials including MRFF grant of >$1.5 million to support a multicenter clinical trial of FET PET imaging in high grade glioma, two Prostate Cancer Research Alliance/ Movember Australia $4 million national grants supporting theranostic approaches to prostate cancer and an MRFF Neurological Disorders grant in Alzheimer’s disease.

A/Prof Francis has been integral in the establishment of Australasian Radiopharmaceutical Trials Network (ARTnet) and has been the inaugural scientific chair since 2014. This network has facilitated several successful multicentre clinical trials in Australia, which have international impact. ARTnet has also established quality programs including PET camera accreditation, and radiopharmaceutical production standards which are critical for imaging validity in multicentre trials.

In 2020 A/Prof Francis was appointed Deputy Director of WA National Imaging Facility (NIF) node. In partnership with WA NIF node Director, Prof Paul Parizel, they are working with UWA and partners to deliver a new dedicated human research imaging facility including 3T MRI and digital PET-CT. This facility will be a significant boost to researchers, patients and clinical trials in Western Australia.

A/Prof Francis has recently collaborated with Prof Martin Ebert to establish the Australian Centre for Quantitative Imaging (ACQI). ACQI represents an innovative approach in medical imaging to enhance and develop opportunities in quantitative imaging and AI.

Privacy Settings
Youtube
Vimeo
Google Maps
Save
We use cookies to enhance your experience while using our website. To learn more about the cookies we use and the data we collect, please check our Privacy Policy .
I Accept